INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

24,511 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
RY
Rozenberg Haine YaelVP Finance
VLNValens Semiconductor Ltd.
Open-market sale · 10b5-1 plan
SELL$2,364
1,458 sh
Oct 19, 2026Oct 21, 2026
Page 66 of 613
← PrevNext →
traded Oct 19, 2026
+2d
SEC Form 4

Evidence

11
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$475K
5,937 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$53K
240 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$65K
280 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$162K
720 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

11
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$148K
640 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

10
PK
Posey Bruce KCHIEF LEGAL OFFICER
QLYSQUALYS, INC.
Open-market sale · 10b5-1 plan
SELL$1,297
7 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

10
PK
Posey Bruce KCHIEF LEGAL OFFICER
QLYSQUALYS, INC.
Open-market sale · 10b5-1 plan
SELL$46K
244 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

10
PK
Posey Bruce KCHIEF LEGAL OFFICER
QLYSQUALYS, INC.
Open-market sale · 10b5-1 plan
SELL$12K
62 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

10
PK
Posey Bruce KCHIEF LEGAL OFFICER
QLYSQUALYS, INC.
Open-market sale · 10b5-1 plan
SELL$6,554
35 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

10
RG
Rajaram GokulDirector
PINSPINTEREST, INC.
Open-market sale · 10b5-1 plan
SELL$24K
1,050 sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC Form 4

Evidence

10
HB
Hohl BenjaminCHIEF FINANCIAL OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$232K
6,018 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

10
PK
Posey Bruce KCHIEF LEGAL OFFICER
QLYSQUALYS, INC.
Open-market sale · 10b5-1 plan
SELL$15K
84 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

10
CL
Collins Helen LouiseCHIEF MEDICAL OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$192K
5,000 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

9
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$289K
11.8K sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

9
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$286K
11.9K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

8
BW
Baumgartner Jeffrey WEVP, R&D
CRUSCIRRUS LOGIC, INC.
Open-market sale · 10b5-1 plan
SELL$126K
1,166 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

8
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
160 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

8
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Open-market sale · 10b5-1 plan
SELL$15K
320 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

8
KH
Khan Salman HassanChief Financial Officer
MARAMARA Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$126K
16.0K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

8
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$189K
14.0K sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

8
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$13K
59 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

7
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$1.11M
13.8K sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC Form 4

Evidence

7
SS
Sijbrandij SytseDirector
GTLBGitlab Inc.
Open-market sale · 10b5-1 plan
SELL$2.29M
42.7K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

7
SS
Sijbrandij SytseDirector
GTLBGitlab Inc.
Open-market sale · 10b5-1 plan
SELL$3.90M
73.5K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

6
PJ
Prahm JeremyChief Investment Officer
FOAFinance of America Companies Inc.
Open-market sale · 10b5-1 plan
SELL$60K
5,610 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

5
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$9,197
115 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

4
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$920K
11.5K sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC Form 4

Evidence

4
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$191K
2,388 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

4
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$229K
2,869 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

4
AH
Anderson David HugoDirector
NWNNorthwest Natural Holding Co
Open-market sale · 10b5-1 plan
SELL$73K
1,500 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

4
PG
Patel Rahul G.Director, See remarks below
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$506K
4,302 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

3
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$2,485
100 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

3
GA
Garefis AmyEVP, Chief People Officer
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$36K
7,879 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

1
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$4,397
55 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

1
GN
Ghamsari NimaDirector, HEAD OF BLEND
BLNDBlend Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$26K
27.8K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

1
MK
Malady KyleEVP and Group CEO-VZ Business
VZVERIZON COMMUNICATIONS INC
Open-market sale · 10b5-1 plan
SELL$49K
1,100 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

1
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$150K
5,882 sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC Form 4

Evidence

1
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$151K
5,999 sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC Form 4

Evidence

0
EE
Eberwein Jeffrey E.Director, Chief Executive Officer, 10% Owner
STRRStar Equity Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$9,100
1,000 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence